Bone and the regulation of global energy balance

Journal of Internal Medicine

Volumn 277, Issue 6, 2015, Pages 681-689

  Zhang, Q ^a   Riddle, R C ^a,b   Clemens, T L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Genetic mouse models; Insulin; Leptin; Osteoblasts

Indexed keywords

ADIPONECTIN; AMINO ACID; GLUCOSE; LEPTIN; LIPID; OSTEOCALCIN; INSULIN; WNT PROTEIN;

ARTICLE; BONE; BONE CELL; BONE DEVELOPMENT; BONE METABOLISM; BONE REMODELING; ENDOCRINE GLAND; ENERGY BALANCE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; ANIMAL; ENERGY METABOLISM; EVIDENCE BASED MEDICINE; METABOLISM; OSTEOBLAST; OSTEOCYTE; WNT SIGNALING PATHWAY;

ADIPONECTIN; ANIMALS; BONE AND BONES; ENERGY METABOLISM; EVIDENCE-BASED MEDICINE; GLUCOSE; HUMANS; INSULIN; LEPTIN; OSTEOBLASTS; OSTEOCALCIN; OSTEOCYTES; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84929353963     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12348     Document Type: Article

References (73)

1. Das KC, White CW. Redox systems of the cell: possible links and implications. Proc Natl Acad Sci USA 2002; 99: 9617-8.
2. Bolton JG, Patel S, Lacey JH, White S. A prospective study of changes in bone turnover and bone density associated with regaining weight in women with anorexia nervosa. Osteoporos Int 2005; 16: 1955-62.
3. Nussbaum M, Baird D, Sonnenblick M, Cowan K, Shenker IR. Short stature in anorexia nervosa patients. J Adolesc Health Care 1985; 6: 453-5.
4. Provot S, Schipani E. Molecular mechanisms of endochondral bone development. Biochem Biophys Res Commun 2005; 328: 658-65.
5. Kronenberg HM. Developmental regulation of the growth plate. Nature 2003; 423: 332-6.
6. Mizoguchi T, Pinho S, Ahmed J et al. Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow development. Dev Cell 2014; 29: 340-9.
7. Ono N, Ono W, Mizoguchi T, Nagasawa T, Frenette PS, Kronenberg HM. Vasculature-associated cells expressing nestin in developing bones encompass early cells in the osteoblast and endothelial lineage. Dev Cell 2014; 29: 330-9.
8. Manolagas SC, Weinstein RS. New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999; 14: 1061-6.
9. Tang Y, Wu X, Lei W et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 2009; 15: 757-65.
10. Bonewald LF. The amazing osteocyte. J Bone Miner Res 2011; 26: 229-38.
11. Weber JM. Metabolic fuels: regulating fluxes to select mix. J Exp Biol 2011; 214: 286-94.
12. Thomas DM, Rogers SD, Sleeman MW et al. Modulation of glucose transport by parathyroid hormone and insulin in UMR 106-01, a clonal rat osteogenic sarcoma cell line. J Mol Endocrinol 1995; 14: 263-75.
13. Li Z, Leslie JM, Wong GW, Kahn BB, Riddle RC, Clemens TL. Expression of glucose transporter-4 by the osteoblast is required for global glucose metabolism. J Bone Miner Res 2013; 28: 1044.
14. Fulzele K, DiGirolamo DJ, Liu Z, Xu J, Messina JL, Clemens TL. Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. J Biol Chem 2007; 282: 25649-58.
15. Zoidis E, Ghirlanda-Keller C, Schmid C. Stimulation of glucose transport in osteoblastic cells by parathyroid hormone and insulin-like growth factor I. Mol Cell Biochem 2011; 348: 33-42.
16. Zoidis E, Ghirlanda-Keller C, Schmid C. Triiodothyronine stimulates glucose transport in bone cells. Endocrine 2012; 41: 501-11.
17. Borle AB, Nichols N, Nichols G Jr. Metabolic studies of bone in vitro. II. The metabolic patterns of accretion and resorption. J Biol Chem 1960; 235: 1211-4.
18. Borle AB, Nichols N, Nichols G Jr. Metabolic studies of bone in vitro. I. Normal bone. J Biol Chem 1960; 235: 1206-10.
19. Schmid C, Steiner T, Froesch ER. Parathormone promotes glycogen formation from [14C]glucose in cultured osteoblast-like cells. FEBS Lett 1982; 148: 31-4.
20. Schmid C, Steiner T, Froesch ER. Insulin-like growth factors stimulate synthesis of nucleic acids and glycogen in cultured calvaria cells. Calcif Tissue Int 1983; 35: 578-85.
21. Felix R, Neuman WF, Fleisch H. Aerobic glycolysis in bone: lactic acid production by rat calvaria cells in culture. Am J Physiol 1978; 234: C51-5.
22. Guntur AR, Le PT, Farber CR, Rosen CJ. Bioenergetics during calvarial osteoblast differentiation reflect strain differences in bone mass. Endocrinology 2014; 155: 1589-95.
23. Komarova SV, Ataullakhanov FI, Globus RK. Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts. Am J Physiol Cell Physiol 2000; 279: C1220-9.
24. Esen E, Chen J, Karner CM, Okunade AL, Patterson BW, Long F. WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation. Cell Metab 2013; 17: 745-55.
25. Regan JN, Lim J, Shi Y et al. Up-regulation of glycolytic metabolism is required for HIF1alpha-driven bone formation. Proc Natl Acad Sci USA 2014; 111: 8673-8.
26. Gimeno RE. Fatty acid transport proteins. Curr Opin Lipidol 2007; 18: 271-6.
27. Herz J, Chen Y, Masiulis I, Zhou L. Expanding functions of lipoprotein receptors. J Lipid Res 2009; 50(Suppl): S287-92.
28. Adamek G, Felix R, Guenther HL, Fleisch H. Fatty acid oxidation in bone tissue and bone cells in culture. Characterization and hormonal influences. Biochem J 1987; 248: 129-37.
29. Niemeier A, Niedzielska D, Secer R et al. Uptake of postprandial lipoproteins into bone in vivo: impact on osteoblast function. Bone 2008; 43: 230-7.
30. Bachner D, Schroder D, Betat N, Ahrens M, Gross G. Apolipoprotein E (ApoE), a Bmp-2 (bone morphogenetic protein) upregulated gene in mesenchymal progenitors (C3H10T1/2), is highly expressed in murine embryonic development. BioFactors 1999; 9: 11-7.
31. Schilling AF, Schinke T, Munch C et al. Increased bone formation in mice lacking apolipoprotein E. J Bone Miner Res 2005; 20: 274-82.
32. Catherwood BD, Addison J, Chapman G, Contreras S, Lorang M. Growth of rat osteoblast-like cells in a lipid-enriched culture medium and regulation of function by parathyroid hormone and 1, 25-dihydroxyvitamin D. J Bone Miner Res 1988; 3: 431-8.
33. Chiu KM, Keller ET, Crenshaw TD, Gravenstein S. Carnitine and dehydroepiandrosterone sulfate induce protein synthesis in porcine primary osteoblast-like cells. Calcif Tissue Int 1999; 64: 527-33.
34. Shapiro I, Haselgrove J. Energy metabolism in bone. In: Hall B, ed. Bone. Boca Raton, FL: CRC Press, 1991; 99-140.
35. Suwazono Y, Kobayashi E, Uetani M et al. G-protein beta 3 subunit polymorphism C1429T and low-density lipoprotein receptor-related protein 5 polymorphism A1330V are risk factors for hypercholesterolemia in Japanese males - a prospective study over 5 years. Metabolism 2006; 55: 751-7.
36. Suwazono Y, Kobayashi E, Uetani M et al. Low-density lipoprotein receptor-related protein 5 variant Q89R is associated with hypertension in Japanese females. Blood Press 2006; 15: 80-7.
37. Suwazono Y, Kobayashi E, Dochi M et al. Combination of the C1429T polymorphism in the G-protein beta-3 subunit gene and the A1330V polymorphism in the low-density lipoprotein receptor-related protein 5 gene is a risk factor for hypercholesterolaemia. Clin Exp Med 2007; 7: 108-14.
38. Guo YF, Xiong DH, Shen H et al. Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study. J Med Genet 2006; 43: 798-803.
39. Lappalainen S, Saarinen A, Utriainen P, Voutilainen R, Jaaskelainen J, Makitie O. LRP5 in premature adrenarche and in metabolic characteristics of prepubertal children. Clin Endocrinol 2009; 70: 725-31.
40. Fujino T, Asaba H, Kang MJ et al. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci USA 2003; 100: 229-34.
41. Magoori K, Kang MJ, Ito MR et al. Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E. J Biol Chem 2003; 278: 11331-6.
42. Patience JF. A review of the role of acid-base balance in amino acid nutrition. J Anim Sci 1990; 68: 398-408.
43. Jewell JL, Russell RC, Guan KL. Amino acid signalling upstream of mTOR. Nat Rev Mol Cell Biol 2013; 14: 133-9.
44. Yang X, Karsenty G. ATF4, the osteoblast accumulation of which is determined post-translationally, can induce osteoblast-specific gene expression in non-osteoblastic cells. J Biol Chem 2004; 279: 47109-14.
45. Yang X, Matsuda K, Bialek P et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 2004; 117: 387-98.
46. Kim SG, Kim HH, Kim HK et al. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells. Anticancer Res 2006; 26: 1989-96.
47. Ducy P, Amling M, Takeda S et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000; 100: 197-207.
48. Takeda S, Elefteriou F, Levasseur R et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002; 111: 305-17.
49. Hinoi E, Gao N, Jung DY et al. The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. J Cell Biol 2008; 183: 1235-42.
50. Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989; 69: 990-1047.
51. Ducy P, Desbois C, Boyce B et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996; 382: 448-52.
52. Lee NK, Sowa H, Hinoi E et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007; 130: 456-69.
53. Ferron M, Wei J, Yoshizawa T et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010; 142: 296-308.
54. Vestri HS, Lara-Castro C, Moellering DR, Gundberg CM, Garvey WT. Osteocalcin is not just for bones: effects on adipocytes and role in human metabolism. Diabetes 2008; 57: A29.
55. Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008; 105: 5266-70.
56. Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 2011; 50: 568-75.
57. Fulzele K, Riddle RC, DiGirolamo DJ et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010; 142: 309-19.
58. Brennan-Speranza TC, Henneicke H, Gasparini SJ et al. Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. J Clin Invest 2012; 122: 4172-89.
59. Henneicke H, Gasparini SJ, Brennan-Speranza TC, Zhou H, Seibel MJ. Glucocorticoids and bone: local effects and systemic implications. Trends Endocrinol Metab 2014; 25: 197-211.
60. Kindblom JM, Ohlsson C, Ljunggren O et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res 2009; 24: 785-91.
61. Yeap BB, Chubb SA, Flicker L et al. Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur J Endocrinol 2010; 163: 265-72.
62. Gower BA, Pollock NK, Casazza K, Clemens TL, Goree LL, Granger WM. Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and beta-cell function in overweight adults. J Clin Endocrinol Metab 2013; 98: E1173-80.
63. Basu R, Peterson J, Rizza R, Khosla S. Effects of physiological variations in circulating insulin levels on bone turnover in humans. J Clin Endocrinol Metab 2011; 96: 1450-5.
64. Winhofer Y, Handisurya A, Tura A et al. Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care 2010; 33: 139-43.
65. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784-92.
66. Maeda N, Shimomura I, Kishida K et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8: 731-7.
67. Shinoda Y, Yamaguchi M, Ogata N et al. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem 2006; 99: 196-208.
68. Kajimura D, Lee HW, Riley KJ et al. Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. Cell Metab 2013; 17: 901-15.
69. Okuno S, Ishimura E, Norimine K et al. Serum adiponectin and bone mineral density in male hemodialysis patients. Osteoporos Int 2012; 23: 2027-35.
70. Zillikens MC, Uitterlinden AG, van Leeuwen JP et al. The role of body mass index, insulin, and adiponectin in the relation between fat distribution and bone mineral density. Calcif Tissue Int 2010; 86: 116-25.
71. Richards JB, Valdes AM, Burling K, Perks UC, Spector TD. Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab 2007; 92: 1517-23.
72. Jurimae J, Jurimae T. Adiponectin is a predictor of bone mineral density in middle-aged premenopausal women. Osteoporos Int 2007; 18: 1253-9.
73. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T. Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur J Endocrinol 2009; 160: 265-73.